Literature DB >> 15168079

[Proliferation and hTERT expression in neuroblastoma].

M Krams1, P Rudolph, D Harms.   

Abstract

BACKGROUND: Transcription of the catalytic subunit of telomerase, human Telomerase Reverse Transcriptase (hTERT), and increased tumor cell proliferation are powerful prognostic factors in neuroblastoma. We therefore investigated their relationship in a large group of neuroblastomas.
METHODS: RT-PCR analysis was used to discriminate between the various hTERT transcripts. Tumor cell proliferation was assessed immunohistochemically using two different cell-cycle specific antibodies and the results were compared by statistical analysis. RESULTS AND
CONCLUSIONS: 54 out of 115 neuroblastomas showed hTERT transcripts, 25 of which also possessed full-length transcripts. Full-length hTERT transcripts were correlated with MYCN-amplification, with a Ki67-proliferation index > or = 25% and a repp86-proliferation index > or = 10% (p<0,0001), but only a Ki67-proliferation index > or = 25% was associated with general hTERT transcription (p=0,001). Our data confirm the close relationship between hTERT transcription and tumor cell proliferation and further strengthen the exceptional prognostic power of the repp86-proliferation index.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168079     DOI: 10.1007/s00292-004-0703-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  22 in total

1.  The expanding role of cell cycle regulators.

Authors:  T Jacks; R A Weinberg
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

2.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter.

Authors:  Y S Cong; J Wen; S Bacchetti
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

3.  Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium.

Authors:  G Bonatz; W Klapper; A Barthe; K Heidorn; W Jonat; G Krupp; R Parwaresch
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

4.  Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.

Authors:  M Krams; A Claviez; K Heidorn; G Krupp; R Parwaresch; D Harms; P Rudolph
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 5.  Telomerase, immortality and cancer.

Authors:  G Krupp; G Bonatz; R Parwaresch
Journal:  Biotechnol Annu Rev       Date:  2000

6.  Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

Authors:  P Rudolph; C Schubert; S Tamm; K Heidorn; A Hauschild; I Michalska; S Majewski; G Krupp; S Jablonska; R Parwaresch
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

7.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.

Authors:  S L Weinrich; R Pruzan; L Ma; M Ouellette; V M Tesmer; S E Holt; A G Bodnar; S Lichtsteiner; N W Kim; J B Trager; R D Taylor; R Carlos; W H Andrews; W E Wright; J W Shay; C B Harley; G B Morin
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

8.  Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.

Authors:  Matthias Krams; Barbara Hero; Frank Berthold; Reza Parwaresch; Dieter Harms; Pierre Rudolph
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

9.  repp86: A human protein associated in the progression of mitosis.

Authors:  Hans-Juergen Heidebrecht; Sabine Adam-Klages; Monika Szczepanowski; Marc Pollmann; Friedrich Buck; Elmar Endl; Marie-Luise Kruse; Pierre Rudolph; Reza Parwaresch
Journal:  Mol Cancer Res       Date:  2003-02       Impact factor: 5.852

10.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

View more
  1 in total

1.  Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification.

Authors:  Subhasree Roy Choudhury; Surajit Karmakar; Naren L Banik; Swapan K Ray
Journal:  Invest New Drugs       Date:  2009-09-24       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.